Juvéderm Vollure™ XC
Juvederm VOLLURE™ XC is the latest and newest addition to the Juvéderm family of facial fillers. JUVÉDERM VOLLURE™ XC softens moderate to severe facial lines and wrinkles to create a smoother appearance. JUVÉDERM VOLLURE™ XC is an FDA-approved Hyaluronic Acid (HA) dermal filler which adds subtle volume to specific facial areas affected by aging. The injectable gel is intended for use in patients who have moderate to severe wrinkles and nasolabial folds. A key US clinical trial saw subjects reporting improvements for up to 18 months post-injection – the longest-lasting treatment ever recorded for a dermal filler in nasolabial folds. There was also high subject satisfaction rate at both 6 and 18 months post-treatment.
Frequently Asked Questions about Juvéderm VOLLURE™ XC
What is Juvéderm VOLLURE™ XC?
JUVÉDERM VOLLURE™ XC is injected into the areas of facial tissue where moderate to severe facial wrinkles and folds occur including the “parentheses lines” around the nose and mouth. JUVÉDERM VOLLURE™ XC is designed to temporarily correct facial wrinkles for a smoother appearance to the face for adults over the age of 21.
How long does Juvéderm VOLLURE™ XC last?
The clinical study demonstrated JUVÉDERM VOLLURE™ XC lasts up to 18 months, with optimal treatment.
What are the potential side effects of Juvéderm VOLLURE™ XC?
The most common side effects included firmness, swelling, tenderness to touch, lumps/bumps, redness, pain, bruising, itching, and discoloration at the injection site. These side effects were usually mild or moderate in nature (causing little to some discomfort and impact on daily activities) and lasted 14 days or less.
How does Juvéderm VOLLURE™ XC work?
Over time, due to a variety of environmental and genetic factors, wrinkles develop on your face, and nasolabial folds may become more visible. JUVÉDERM VOLLURE™ XC is designed to temporarily add volume to the facial wrinkles for a smoother appearance to the face. The lidocaine in the gel improves the comfort of the injection by reducing sensitivity to pain.